Free tool
Stocks above their 200-day average
We cover 8 companies trading above their own 200-day average. The median market value in the group is $217.22B. Across the group, the median move over the past trading day is +0.92%. Price change over the past year runs from −49.4% to +56.5% across the middle 80 percent of the group, with a median of +20.3%.
Other lists in this group
Table
8 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% | Oct 13, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% | Oct 21, 2026 |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% | Oct 14, 2026 |
| ONCIN.OL | Oncoinvent ASA | $43.71M | Micro cap | +10.90% | Aug 27, 2026 |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% | Sep 3, 2026 |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% | Sep 23, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.